{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:24:01Z","timestamp":1745555041773,"version":"3.40.4"},"reference-count":48,"publisher":"Royal College of General Practitioners","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJGP Open"],"accepted":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Women who use drugs face specific challenges compared with men such as higher rates of HIV infection, unsafe injecting practices, and intimate partner violence (IPV). However, this population\u2019s access to drug dependence treatment and gender-sensitive interventions remains limited, leading to unmet needs and increased vulnerability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate the characteristics of and associations with retention in care among women on opioid substitution therapy (OST) in a community-based primary care setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design &amp; setting<\/jats:title><jats:p>A descriptive observational study within the Community Orientated Substance Use Programme in Tshwane, South Africa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Data from 199 women (aged<jats:underline>&gt;<\/jats:underline>18 years) on OST was extracted from an electronic database and paper-based files. Data were analysed descriptively, and inferential analysis looked for association of variables with retention on OST for \u22656 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority of participants were unemployed, with 44.3% aged 20\u201329 years. During the initiation and course of OST, 39.2% of women had an intimate partner of which 37.2% reported IPV, and 19.2% were pregnant. Retention on OST was significantly associated with increasing age at initiation (<jats:italic>P<\/jats:italic>= 0.047), knowledge of HIV status (<jats:italic>P<\/jats:italic>= 0.029), an increase in the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) score (<jats:italic>P<\/jats:italic>= 0.023), and methadone dose (<jats:italic>P<\/jats:italic>&lt;0.001). Factors such as race, employment status, health-system level, pregnancy, intimate partner using substances, IPV, route of administering opioids, and having tuberculosis and\/or hepatitis C exposure did not show a significant relationship with retention on OST (<jats:italic>P<\/jats:italic>&gt;0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study reveals specific vulnerabilities in women receiving OST, emphasising the need for the integration of interventions to address reproductive health, violence mitigation, infectious disease, and polydrug use into care.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgpo.2024.0049","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:51:19Z","timestamp":1738115479000},"page":"BJGPO.2024.0049","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study"],"prefix":"10.3399","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8647-1350","authenticated-orcid":false,"given":"Daniela S","family":"Goeieman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-0774","authenticated-orcid":false,"given":"Robert","family":"Mash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-9540","authenticated-orcid":false,"given":"Natasha R","family":"Gloeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-0699","authenticated-orcid":false,"given":"Andrew","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"2025042418001315000_9.1.BJGPO.2024.0049.1","unstructured":"United Nations Office on Drugs and Crime (2021) World Drug Report 2021. accessed. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.2","unstructured":"Dada S Harker Burnhams N Erasmus J Lucas Charles Parry W et al (2020) South African community epidemiology network on drug use. SACENDU Report. accessed. https:\/\/www.samrc.ac.za\/sites\/default\/files\/attachments\/2022-07\/SACENDUFullReportPhase48.pdf. 12 Jan 2025."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.4","unstructured":"The Global Fund (2022) Technical brief: Harm reduction for people who use drugs \u2014 priorities for investment and increased impact in HIV programming. Allocation period 2023\u20132025, accessed. https:\/\/www.theglobalfund.org\/media\/1279\/core_harmreduction_infonote_en.pdf. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.5","unstructured":"South African National AIDS Council (2019) Midterm Review of the National Strategic Plan for HIV, TB and STIs 2017\u20132022, accessed. https:\/\/sanac.org.za\/wp-content\/uploads\/2021\/05\/MTR-Summary-Report-NSP-Final.pdf. 12 Jan 2025."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.6","unstructured":"International AIDS Society (2019) Women who inject drugs: overlooked, yet visible, accessed. https:\/\/www.iasociety.org\/Web\/WebContent\/File\/2019__IAS__Brief__Women_who_inject_drugs.pdf. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.7","unstructured":"National Institute on Drug Abuse (2021) Substance use in women research report: summary, accessed. https:\/\/nida.nih.gov\/publications\/research-reports\/substance-use-in-women\/summary. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.09.003"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.9","unstructured":"Harm Reduction International (2020) Global state of harm reduction 2020, accessed. https:\/\/www.hri.global\/files\/2021\/03\/04\/Global_State_HRI_2020_BOOK_FA_Web.pdf. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.10","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00479-3"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230886"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.01.022"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2018.08.002"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.14","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000720"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.15","unstructured":"World Health Organization United Nations Office on Drugs and Crime (2020) International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing (Geneva: WHO, UNODC), accessed. https:\/\/apps.who.int\/iris\/handle\/10665\/331635. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.16","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2017.1300634"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011117.pub3"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0298-2"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00619-X"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.04.210"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.21","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v12i1.2285"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.22","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v13i1.2416"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.23","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2020.v111i1.14884"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.01.004"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.25","unstructured":"World Health Organization (2010) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. accessed. https:\/\/www.who.int\/publications\/i\/item\/978924159938-2. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.26","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v14i1.3386"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204956"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103059"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.29","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0307-5"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02249.x"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.31","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctv11313rg.6"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.32","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13421"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0235-9"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.34","doi-asserted-by":"publisher","DOI":"10.1177\/00027162221142644"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.35","unstructured":"South African Addiction Medicine Society (2015) South African Guidelines for the Management of Opioid Use Disorders, accessed. https:\/\/saams.co.za\/assets\/docs\/Microsoft%20Word%20-%20South%20African%20Guidelines%20for%20the%20Management%20of%20Opioid%20use%20disorders%20-%202015.docx.pdf. 12 Jan 2025."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.36","unstructured":"Humeniuk R Henry-Edwards S Ali R et al (2010) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care (WHO, Geneva)."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.37","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00095-0"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067062"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108399"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.40","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11183-z"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.41","unstructured":"Women and Harm Reduction International Network (WHRIN) (2021) Global mapping of harm reduction services for women who use drugs, accessed. https:\/\/whrin.site\/ourpublication\/global-mapping-of-harm-reduction-services-for-women-who-use-drugs-english\/. 5 Nov 2024."},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.42","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v12i1.2285"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32277-3"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.44","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v21i1.1161"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.45","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0165-y"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.46","doi-asserted-by":"publisher","DOI":"10.3310\/hta11030"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.47","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-021-00858-z"},{"key":"2025042418001315000_9.1.BJGPO.2024.0049.48","unstructured":"Clinton Health Access Initiative (CHAI) (2023) HCV market intelligence report. accessed. https:\/\/chai19.wpenginepowered.com\/wp-content\/uploads\/2023\/12\/CHAI-HCV-Market-Intelligence-Report-2023.pdf. 5 Nov 2024."}],"container-title":["BJGP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGPO.2024.0049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:01:03Z","timestamp":1745542863000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgpopen.org\/lookup\/doi\/10.3399\/BJGPO.2024.0049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.3399\/BJGPO.2024.0049"],"URL":"https:\/\/doi.org\/10.3399\/bjgpo.2024.0049","relation":{},"ISSN":["2398-3795"],"issn-type":[{"type":"electronic","value":"2398-3795"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}